News about "Companion Diagnostic"

FDA Expands Approval of Agilent's PD-L1 Diagnostic Test on Dako Omnis Platform for Four Additional Cancer Types

FDA Expands Approval of Agilent's PD-L1 Diagnostic Test on Dako Omnis Platform for Four Additional Cancer Types

Agilent Technologies has received FDA approval to expand the use of its PD-L1 IHC 22C3 pharmDx test on the Dako Omnis platform, broadening access to PD-L1 testing for four additional tumour types and supporting streamlined pathology laboratory operations.

Companion Diagnostic | 05/06/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members